Integral Health Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-300,000
| Closed | -$558K | – | 73 |
|
|
2022
Q2 | $558K | Buy |
+300,000
| New | +$558K | 0.11% | 63 |
|
|
2022
Q1 | – | Sell |
-200,000
| Closed | -$788K | – | 82 |
|
|
2021
Q4 | $788K | Sell |
200,000
-150,000
| -43% | -$591K | 0.22% | 65 |
|
|
2021
Q3 | $1.68M | Buy |
+350,000
| New | +$1.68M | 0.48% | 57 |
|
|
2021
Q1 | – | Sell |
-300,000
| Closed | -$1.03M | – | 84 |
|
|
2020
Q4 | $1.03M | Buy |
+300,000
| New | +$1.03M | 0.31% | 56 |
|